Cemex SAB de CV
Cemex SAB de CV operates in various business sectors.
Cemex SAB de CV (CEXA) - Net Assets
Latest net assets as of June 2024: €12.10 Billion EUR
Based on the latest financial reports, Cemex SAB de CV (CEXA) has net assets worth €12.10 Billion EUR as of June 2024.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€28.04 Billion) and total liabilities (€15.94 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €12.10 Billion |
| % of Total Assets | 43.16% |
| Annual Growth Rate | 1.64% |
| 5-Year Change | 11.94% |
| 10-Year Change | N/A |
| Growth Volatility | 11.49 |
Cemex SAB de CV - Net Assets Trend (2018–2023)
This chart illustrates how Cemex SAB de CV's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Cemex SAB de CV (2018–2023)
The table below shows the annual net assets of Cemex SAB de CV from 2018 to 2023.
| Year | Net Assets | Change |
|---|---|---|
| 2023-12-31 | €12.12 Billion | +11.06% |
| 2022-12-31 | €10.91 Billion | +6.21% |
| 2021-12-31 | €10.27 Billion | +14.73% |
| 2020-12-31 | €8.95 Billion | -17.29% |
| 2019-12-31 | €10.82 Billion | -3.10% |
| 2018-12-31 | €11.17 Billion | -- |
Equity Component Analysis
This analysis shows how different components contribute to Cemex SAB de CV's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 176.6% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2023)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | €4.43 Billion | 37.64% |
| Other Components | €7.34 Billion | 62.36% |
| Total Equity | €11.76 Billion | 100.00% |
Cemex SAB de CV Competitors by Market Cap
The table below lists competitors of Cemex SAB de CV ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Tetra Bio-Pharma Inc.
PINK:TBPMQ
|
$83.75K |
|
VHABW
PINK:VHABW
|
$83.88K |
|
IQ-AI LTD. LS -01
F:5Y1
|
$83.93K |
|
Pioneer High Income Closed Fund
NYSE:PHT
|
$83.97K |
|
Il-Yang Pharmaceutical Co. Ltd.
KQ:007570
|
$83.74K |
|
XPS Pensions Group PLC
LSE:XPS
|
$83.71K |
|
CI Com SA
SW:CIE
|
$83.71K |
|
Ilshin Spinning Co. Ltd.
KQ:003200
|
$83.63K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Cemex SAB de CV's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2022 to 2023, total equity changed from 10,501,000,000 to 11,764,000,000, a change of 1,263,000,000 (12.0%).
- Net income of 182,000,000 contributed positively to equity growth.
- Other factors increased equity by 1,081,000,000.
Equity Change Factors (2022 to 2023)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €182.00 Million | +1.55% |
| Other Changes | €1.08 Billion | +9.19% |
| Total Change | €- | 12.03% |
Book Value vs Market Value Analysis
This analysis compares Cemex SAB de CV's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 33.30x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 42.20x to 33.30x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2018-12-31 | €0.21 | €9.00 | x |
| 2019-12-31 | €0.21 | €9.00 | x |
| 2020-12-31 | €0.18 | €9.00 | x |
| 2021-12-31 | €0.22 | €9.00 | x |
| 2022-12-31 | €0.24 | €9.00 | x |
| 2023-12-31 | €0.27 | €9.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Cemex SAB de CV utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 1.55%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 1.05%
- • Asset Turnover: 0.61x
- • Equity Multiplier: 2.42x
- Recent ROE (1.55%) is above the historical average (0.70%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2018 | 5.55% | 3.78% | 0.50x | 2.93x | €-427.31 Million |
| 2019 | -0.56% | -0.41% | 0.43x | 3.15x | €-984.10 Million |
| 2020 | -18.17% | -11.58% | 0.46x | 3.40x | €-2.27 Billion |
| 2021 | 7.66% | 5.24% | 0.54x | 2.71x | €-229.70 Million |
| 2022 | 8.17% | 5.51% | 0.59x | 2.52x | €-192.10 Million |
| 2023 | 1.55% | 1.05% | 0.61x | 2.42x | €-994.40 Million |
Industry Comparison
This section compares Cemex SAB de CV's net assets metrics with peer companies in the same industry.
No peer company data available for comparison.